cyfluthrin has been researched along with quinupristin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malathum, K; Murray, BE; Singh, KV | 1 |
| Astfalk, N; Jagusch, H; Petridou, J; Scheuring, S; Schmitz, FJ; Schwarz, S | 1 |
| Astfalk, N; Köhrer, K; Petridou, J; Scheuring, S; Schmitz, FJ; Schwarz, S | 1 |
3 other study(ies) available for cyfluthrin and quinupristin
| Article | Year |
|---|---|
In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Gram-Positive Cocci; Ketolides; Microbial Sensitivity Tests; Virginiamycin | 2001 |
Molecular characterization of ketolide-resistant erm(A)-carrying Staphylococcus aureus isolates selected in vitro by telithromycin, ABT-773, quinupristin and clindamycin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clindamycin; DNA Transposable Elements; Drug Resistance, Bacterial; Erythromycin; Ketolides; Macrolides; Methyltransferases; Mutation; Staphylococcus aureus; Virginiamycin | 2002 |
Molecular analysis of constitutively expressed erm(C) genes selected in vitro by incubation in the presence of the noninducers quinupristin, telithromycin, or ABT-773.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Genes, Bacterial; In Vitro Techniques; Ketolides; Macrolides; Microbial Sensitivity Tests; Mutation; Protein Biosynthesis; Selection, Genetic; Staphylococcus aureus; Virginiamycin | 2002 |